The statistically significant differences in the reporting of specific side effects (e.g., abnormal lab findings, gastrointestinal, and hepatobiliary effects) indicate that a users understanding of semaglutides risk profile is not based solely on clinical evidence, but is heavily mediated by the platform they use (6, 46)
For more information, visit novonordisk.com and novonordisk-us.com , and follow us on Facebook , Instagram , X , LinkedIn , and YouTube
While data on first-trimester exposure is still being gathered, the most helpful first step is simply to reach out to your healthcare team
In the case of compounded GLP-1 medications, prescriptions are fulfilled by licensed U.S
This method can often help to minimize side effects as it allows time for the body to adjust to the medication